The biomarkers (S100A4, CA-125, and CA 19-9) correlated with poor overall survival (p < 0.05). Pancreatic cancer patients with abnormal levels of two or more of the presented markers had significantly shorter survival than patients with an abnormal result of ≤1 marker (p < 0.05) [73]....